Alcidion Group Limited · ASX:ALC
Alcidion — Investor Presentation (November 2019)
12 slides from Alcidion's investor presentation, Nov 5, 2019
Slide 1: Capital Raising Presentation October / November 2019
For personal use only Capital Raising Presentation October / November 2019 1
Slide 2: Better lives by transforming healthcare delivery through smart technology
For personal use only Better lives by transforming healthcare delivery through smart technology 30K 215 42 • Highly differentiated platform Beds using our technology Hospitals across the UK, Australia, New Healthcare organisations providing smart infrastructure for Zealand transforming healthcare wi
Slide 3: Uniquely placed to transform healthcare delivery
Uniquely placed to transform For personal use only healthcare delivery • Miya Precision is an innovative events driven platform • Adds real value to existing investment in Electronic Medical Records (EMR) • Better decisions engineering the risk out of healthcare, pushed to the point of care • Busine
Slide 4: Our opportunity to accelerate growth
For personal use only Our opportunity to accelerate growth 4
Slide 5: Capitalising on the Growth Opportunity
Capitalising on the Growth Opportunity For personal use only The Growth Opportunity • Significant global market opportunity - digital patient data driving demand • Regulatory environment leading technology adoption in healthcare • A leading-edge technology suite and differentiated product offering •
Slide 6: Australia – ready to expand
Australia – ready to expand For personal use only Current state of play Alcidion today Global Market potential - 5 years • EMR penetration in public sector is Opportunity to increase share of beds high: 60-70% of hospitals (beds) covered by part or all EMR • Hospital spending rising by 4.2% per annu
Slide 7: UK – our largest current market
UK – our largest current market For personal use only Current state of play Alcidion today Global Market potential - 5 years • Early adopter of new technology Opportunity to increase share of beds within Europe, less EMR penetration, hybrid approach • including best of breed NHSX - government leadin
Slide 8: NZ - strong existing presence provides future potential to upsell
NZ - strong existing presence provides future potential to upsell For personal use only Current state of play Alcidion today Global Market potential - 5 years • Best of breed more commonly used Opportunity to increase share of beds over integrated EMR • Patientrack clear market leader for patient ob
Slide 9: Opportunity in additional markets
Opportunity in additional markets For personal use only Number of Hospitals by Region (2016) • Similar drivers for adoption exist • Shift to digitalisation still at an early stage 700,000 in many markets • Currently analysing markets with earliest potential • Canada, Singapore, South Africa, 387,000
Slide 10: Why invest in Alcidion
Why invest in Alcidion For personal use only • Positioned to capture large market opportunity at the right time, as healthcare undergoes digital transformation • Differentiated offering and unique tech platform – delivering solutions for a range of hospital needs with strong cross-selling opportunit
Slide 11: Contacts
Contacts For personal use only Justin Lewis Managing Director Henslow jlewis@henslow.com +61 439 162 369 Kyahn Williamson Head of Investor Communication WE Communications Kwilliamson@we-worldwide.com +61 401 018 828 11
Slide 12: Disclaimer
Disclaimer For personal use only This presentation has been prepared by Alcidion Group Limited (‘Alcidion’). The information in this presentation is of a general nature and does not purport to be complete, nor does it contain all the information which would be required in a prospectus prepared in ac
Alcidion Group — Investor Presentation (November 2019) on 6ix